The Maharashtra FDA has cancelled drug sale and distribution licences for Cipla's Wadki warehouse in Pune over violations including misbranding of Reactin Plus, poor storage, and record-keeping lapses. Cipla called the decision disappointing and said it is reviewing the order. The action follows a Bombay High Court-directed fresh proceeding.
Maharashtra FDA Cancels Cipla Pune Warehouse Licences
Source: Mint